一线抗高血压药物类别的综合比较有效性和安全性:系统的,跨国的大规模分析
Marc A Suchard1, Martijn J Schuemie2, Harlan M Krumholz3
1Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, CA, USA; Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
Lancet (London, England)
|November 1, 2019
概括
与单独治疗高血压时使用的ACE抑制剂相比, thiazide利尿剂的有效性和安全性更高. 发现非二皮类通道阻塞剂的效果低于其他一线选择.
科学领域:
- 心血管医学
- 药理学
- 现实世界的证据研究
背景情况:
- 对高血压的最佳一线单一治疗仍然不确定,目前的指南提供了广泛的选择.
- 随机试验没有明确区分主要抗高血压药物的有效性.
研究的目的:
- 开发和应用现实世界的新框架来比较一线高血压单一疗法的有效性和安全性.
- 通过大规模的观察数据,评估不同药物类别中主要心血管事件的相对风险和安全结果.
主要方法:
- 创建了一个全面的现实世界证据框架,以尽量减少观察数据分析中的偏见.
- 在全球行政索赔和电子健康记录网络中采用了新用户队列设计.
- 使用大规模的倾向评分调整和全面的对照结果来解决混和其他偏差.
主要成果:
- 对490万患者的分析显示,与血管激素转化酶抑制剂相比,酸或酸类利尿剂对心肌梗塞,心力衰竭住院和中风具有更高的初级疗效.
- 与血管素转化酶抑制剂相比,酸性利尿剂的安全性更为良好.
- 发现非二皮里丁通道阻断剂的效果明显低于其他四种一线药物类别.
结论:
- 开发的框架允许对现实世界健康数据进行大规模的比较有效性和安全性研究.
- 结果支持大多数一线高血压单一疗法的等价性,但有显著的例外: thiazide利尿剂优于血管激素转化酶抑制剂,而非二皮里丁通道阻断剂则劣.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
542
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
542
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
863
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
863
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.3K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.3K
Antihypertensive Drugs: Thiazide-Class Diuretics
1.5K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K


